In this study, through retrospective analysis of ovarian cancer patients’ transcriptome data, we found that ovarian cancer cells in BRCA1-deficient patients expressed higher levels of ADRB1, which can enable adenylyl cyclase to generate cAMP. Here, ADRB1 is linked to ovarian cancer.